NCT06341439

Clinical Efficacy of Mouthrinses Based on Chlorhexidine 0.12% and CITROX®

Name: Clinical Trial NCT06341439
Creator: University of L'Aquila
Keywords: Periodontitis, Mouthwash with chlorhexidine 0,12% and CITROX, device, clinical trial, Italy

Clinical Efficacy of Mouthrinses Based on Chlorhexidine 0.12% and CITROX® as a Support to Non-surgical Periodontal Therapy: a Randomized Controlled Triple-blind Clinical Trial

University of L'Aquila·ClinicalTrials.gov·device·Device trialRecruitment Completed

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Periodontitis
Drug/Device/Intervention: Mouthwash with chlorhexidine 0,12% and CITROX
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: University of L'Aquila
Location: L'Aquila, Italy

Timeline & enrollment

Phase: N/A
Start date: Feb 18, 2023
End date: Mar 30, 2024
Enrollment: 40 participants

Primary outcome

Probing Depth (PD),Gingival Index (GI),Plaque Index (PI),Full mouth plaque score (FMPS),Full mouth bleeding score (FMBS)

Summary

The goal of the following clinical trial is to compare the efficacy of a product based on chlorhexidine 0.12% and CITROX and the same product without CITROX in the healing phenomena that occur after non-surgical periodontal therapy. The main questions it aims to answer are:  - Is the response to periodontal therapy better if mouthwash containing Citrox is used?  - What is the patients' perception?  Participants, divided into 2 groups, are asked to use either one or the other mouthwash for 14 days after non-surgical periodontal therapy.

ICD-10 classifications

Chronic periodontitisPeriodontosisAcute periodontitisChronic apical periodontitisPeriodontal disease, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06341439
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06341439 through Pure Global AI's free database. This phase not specified trial is sponsored by University of L'Aquila and is currently Recruitment Completed. The study focuses on Periodontitis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.